Core Viewpoint - The article discusses the performance of private equity products based on the Sharpe ratio, highlighting the top-performing products over the past year, three years, and five years, emphasizing the balance between risk and return in investment strategies [1][8][13]. Group 1: One-Year Performance - The top 20 private equity products with the highest Sharpe ratios over the past year include 12 subjective long products, 4 quantitative long products, and 4 market-neutral products [1]. - The average return for the 2569 stock strategy products in the past year was 24.84%, with 1054 products exceeding this average [1]. - The leading product, "量魁湘水麓山五号," managed by Liang Tao from 量魁私募, achieved the highest Sharpe ratio and return, although specific figures are redacted [5][6]. Group 2: Three-Year Performance - In the three-year category, there were 1627 stock strategy products, with an average return of 39.41% and 617 products surpassing this average [8]. - The top five products were managed by 积露资产, 量魁私募, 敦颐资产, and 垒昂资产, with a notable presence of market-neutral and subjective long strategies [8][9]. - The leading product, "积露11号," managed by Yang Zhongxian from 积露资产, topped the list with a high Sharpe ratio and return, specific figures are also redacted [12]. Group 3: Five-Year Performance - For the five-year performance, 763 stock strategy products were analyzed, with an average return of 86.13% and 284 products exceeding this average [13]. - The top five products included those managed by 量魁私募, 积露资产, and 九坤投资, with a majority being subjective long strategies [13][14]. - The product "量魁湘水麓山五号" again featured prominently, indicating consistent performance over multiple time frames [15].

Core Viewpoint - The article emphasizes the power of compound interest and the challenges of achieving consistent positive returns in the current complex market environment, particularly in the A-share market, where the CSI 300 index has shown significant fluctuations since 2021, with a cumulative decline of 27.65% as of April 30, 2025 [2][3]. Summary by Category Market Performance - Since 2021, the CSI 300 index has experienced annual returns of -5.20%, -21.63%, -11.38%, 14.68%, and -4.18%, with only one year showing positive returns [2]. - The cumulative return from 2021 to April 30, 2025, is -27.65%, indicating a challenging environment for private equity funds to achieve consistent positive returns [2]. Private Equity Fund Performance - As of April 2025, among 926 private equity products (excluding pure bond strategies), only 238 products (approximately 25.7%) have achieved positive returns each year since 2021 [3]. - The successful products are nearly evenly split between quantitative (114 products) and non-quantitative (124 products) strategies [3]. Top Performing Products - The top five products with the highest cumulative returns since 2021 are from JiLu Asset, Shanghai Liangyu Private Equity, JiuKun Investment, and Guangzhou Shouzheng Yiqi [4]. - Notable products achieving over ***% returns since 2021 include JiuKun's "JiuKun Day Enjoy CSI 1000 Index Enhanced No. 1" and Liang Kui's "Liang Kui Xiang Shui Lu Mountain No. 5" [4][12]. Strategy Breakdown - In the quantitative strategy category, there are 35 products that have achieved positive returns each year since 2021, with 16 being from large private equity firms [3][13]. - The subjective long-only equity strategy has 37 products with consistent positive returns, with 20 from large private equity firms [13][14]. Multi-Asset and Other Strategies - There are 33 multi-asset strategy products that have shown positive returns each year since 2021, with 6 from large private equity firms [18]. - In the futures and derivatives strategy category, 35 products have achieved positive returns since 2021, with 4 from large private equity firms [24]. - The bond strategy category has 15 products with consistent positive returns, with 1 from a large private equity firm [27]. Overall Trends - A total of 47 large private equity products have achieved positive returns each year since 2021, with a significant representation from subjective long-only equity strategies [31].